Mahesh V Padval Selected Research

prednisolone drug combination dipyridamole

9/2009

Biotransformation and in vitro assessment of metabolism-associated drug-drug interaction for CRx-102, a novel combination drug candidate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mahesh V Padval Research Topics

Disease

1	Neoplasms (Cancer) 01/2015
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2015
1	Multiple Sclerosis 01/2011
1	Autoimmune Diseases (Autoimmune Disease) 01/2011
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2011
1	Osteoarthritis 09/2009

Drug/Important Bio-Agent (IBA)

1	VS-5584IBA 01/2015
1	Cisplatin (Platino)FDA LinkGeneric 01/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2015
1	Nortriptyline (Aventyl)FDA LinkGeneric 01/2011
1	Histamine Antagonists (Antihistamines)IBA 01/2011
1	Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA 01/2011
1	desloratadine (Aerius)FDA LinkGeneric 01/2011
1	Interferon-gamma (Interferon, gamma)IBA 01/2011
1	Interleukin-17 (Interleukin 17)IBA 01/2011
1	prednisolone drug combination dipyridamoleIBA 09/2009

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2015